Edit |   |
---|---|
Antigenic Specificity | ANGPT2, Human (Nesvacumab biosimilar) |
Clone | Nesvacumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ANGPT2 Recombinant Antibody. Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema. This drug is being developed by Regeneron Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-ANGPT2 Recombinant Antibody, Research Grade Nesvacumab, Anti-Human ANGPT2 Recombinant Antibody, REGN-910, Antibody Drug Analogues, Monoclonal Antibody, YR1297, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1296818-77-3 |
Catalog # | YR1297 |
Price | please inquire |
Order / More Info | ANGPT2, Human (Nesvacumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |